Subject Index to Volume 33, 2020 ================================ * **Abstracting and indexing,** peer review of abstracts submitted to academic meetings, 33(6):986–991 * **Academies and institutes,** intrinsically motivated learners, 33(5):S21–S23 * **Access to health care** * addressing needs of transgender patients, 33(2):314–321 * decline in pediatric care by family physicians, 33(2):314–321 * HPV vaccination among adult males, 33(4):592–599 * insurance, health care, and discrimination, 33(4):580–591 * **Accountable care organizations,** Medicare Access and CHIP Reauthorization Act, 33(6):942–952 * **Accreditation,** clinical learning environment and health care delivery, 33(5):S46–S49 * **Accreditation Council for Graduate Medical Education (ACGME),** impact of changes to residency requirements, 33(6):1033–1036 * **Acute pain,** patient “catastrophizing” and expectations of opioid prescriptions, 33(6):858–870 * **Addictive behavior** * quality improvement toolkit to improve opioid prescribing, 33(1):17–26 * systematic approach to opioid prescribing, 33(6):992–997 * **Adenoidectomy,** current indications for, 33(6):1025–1030 * **Administrative personnel,** patient safety in primary care, 33(5):754–764 * **Adolescents,** stimulant use by, for ADHD, 33(1):59–70 * **Advance care planning,** prognostic indices for, 33(2):322–338 * **Adverse drug events,** inappropriate medications for elderly patients, 33(4):561–568 * **Aftercare,** initiative to reduce avoidable hospital admissions, 33(6):1011–1015 * **Aging** * cognitive functioning, subjective vs. objective assessment, 33(3):417–425 * elderly patients, prescribing inappropriate medications for, 33(4):561-568 * surveillance colonoscopies in older adults with prior adenomas, 33(5):796–798 * usual source of care and longer telomere length, 33(6):832–841 * **Alcohol drinking,** unhealthy, machine learning approach to, 33(3):397–406 * **Alcoholism,** machine learning approach to unhealthy drinking, 33(3):397–406 * **Allied health personnel,** financial cost of medical assistant turnover, 33(3):426–430 * **Altruism,** virtual Parent Panel for pediatric research network, 33(5):665–674 * **Ambulatory care,** educating patients on unnecessary antibiotics, 33(6):969–977 * **Ambulatory care facilities** * eliminating barriers to improve quality of care, 33(2):220–229 * practical management of common skin injuries, 33(5):799–808 * **American Board of Family Medicine (ABFM)** * celebrating 50 years of continuing transformation, 33(5):S69–S74 * efforts to advance leadership and scholarship in family medicine, 33(1):156–159 * Family Medicine Certification Longitudinal Assessment, after one year, 33(2):344–346 * **American Medical Association,** buprenorphine prescribers for Medicare patients, 33(1):9–16 * **Amphetamines,** marketing messages in continuing medical education on binge-eating disorder, 33(2):240–251 * **Anesthesiology,** rethinking the purpose of MOC, 33(5):S15–S20 * **Angiotensin-converting enzyme inhibitors,** anti-hypertensive medication combinations, 33(1):143–146 * **Anti-HMGCR myopathy,** from statins, 33(5):785–788 * **Antibacterial drug resistance,** educating patients on unnecessary antibiotics, 33(6):969–977 * **Antibiotics** * misdiagnosis of diverticulitis after IBS diagnosis, 33(4):549–560 * unnecessary, educating patients on, 33(6):969–977 * **Antidepressants** * patient education level and, 33(1):80–90 * risk-reduction tools and an opioid-prescribing protocol, 33(1):27–33 * **Antihypertensive agents,** medication combinations, 33(1):143–146 * **Antimicrobial stewardship,** educating patients on unnecessary antibiotics, 33(6):969–977 * **Area under curve,** machine learning approach to unhealthy drinking, 33(3):397–406 * **Arizona,** unexpected career retirement, 33(2):339–341 * **Asthma,** care, in a multi-state network of low-income children, 33(5):707–715 * **Atopic dermatitis,** diagnosis and management, 33(4):626–635 * **Attention deficit hyperactivity disorder,** stimulant use by young adults, 33(1):59–70 * **Automobile driving,** opioid use and, among older adults, 33(4):521–528 * **Back pain** * low, adults with, widespread pain in, 33(4):541–549 * opioid prescriptions for, 33(1):138–142 * **Behavior therapy,** obesity intervention trial, participation of rural clinicians, 33(5):736–744 * **Behavioral Risk Factor Surveillance System,** HPV vaccination among adult males, 33(4):592–599 * **Benzodiazepines** * risk-reduction tools and an opioid-prescribing protocol, 33(1):27–33 * systematic approach to opioid prescribing, 33(6):992–997 * **Binge-eating disorder,** marketing messages in continuing medical education on, 33(2):240–251 * **Bioethics,** managing patient requests for marijuana, 33(1):147–151 * **Biomedical technology assessment,** clinical decision support for opioid prescribing, 33(4):529–540 * **Biostatistics,** peer review of abstracts submitted to academic meetings, 33(6):986–991 * **Blood glucose,** social and clinical complexity on diabetes control, 33(4):600–610 * **Blood pressure,** practice transformation support and cardiovascular care, 33(5):675–686 * **BRCA1 gene,** BRCA-related cancer genetic counseling, 33(6):885–893 * **BRCA2 gene,** BRCA-related cancer genetic counseling, 33(6):885–893 * **Breast cancer** * BRCA-related cancer genetic counseling, 33(6):885–893 * screening * ▪ for average-risk women, 33(6):871–884 * ▪ and shared decision making, 33(3):473–480 * **Built environment,** for professionalism, 33(5):S57–S61 * **Buprenorphine** * financial model for opioid use disorder, 33(1):124–128 * office-based opioid treatment models, 33(4):512–521 * OUD education and waiver provision during residency, 33(6):998–1003 * patient retention in opioid medication-assisted treatment, 33(6):848–857 * prescribers, for Medicare patients, 33(1):9–16 * prescribing, early-career physicians and, 33(1):7–8 * prescribing by family physicians, 33(1):118–123 * treating opioid use disorder in family medicine, 33(4):611–615 * **Burns,** practical management of, 33(5):799–808 * **California** * gender differences in addressing burnout, 33(3):446–451 * insurance, health care, and discrimination, 33(4):580–591 * **Canada,** strategies to overcome psychological insulin resistance, 33(2):198–210 * **Cannabis,** managing patient requests for marijuana, 33(1):147–151 * **Capacity building,** indicators of workplace burnout, 33(3):378–385 * **Cardiovascular disease** * anti-HMGCR myopathy from statins, 33(5):785–788 * glucosamine/chondroitin and mortality, 33(6):842–847 * heart disease in adult Down syndrome, 33(6):923–931 * practice facilitation barriers in quality improvement, 33(5):655–664 * practice transformation support and cardiovascular care, 33(5):675–686 * screening for, in breast cancer survivors, 33(6):894–902 * **Case-control studies,** cardiovascular screening and lipid management in breast cancer survivors, 33(6):894–902 * **Case report,** anti-HMGCR myopathy from statins, 33(5):785–788 * **Catastrophization** * and expectations of opioid prescriptions, 33(6):871–884 * widespread pain in adults with low back pain, 33(4):541–549 * **Causality,** HPV vaccination among adult males, 33(4):592–599 * **Central nervous system stimulants,** use by young adults for ADHD, 33(1):59–70 * **Certification** * celebrating 50 years of continuing transformation, 33(5):S69–S74 * continuing board certification, 33(5):S10–S14 * evolution of board certification, 33:(5)S1–S9 * helping family physicians keep up to date, 33(5):S24–S27 * measuring and improving quality in the US, 33(5):S28–S35 * medical professionalism, 33(5):S62–S64, 33(5):S65–S68 * quality improvement teams, 33(5):S42–S45 * rethinking the purpose of MOC, 33(5):S15–S20 * role of certifying boards in improving health, 33(5):S36–S41 * **Chi-square test,** patient education level and antidepressants, 33(1):80–90 * **Child health** * asthma care in a multi-state network of low-income children, 33(5):707–715 * co-management for sickle cell disease, 33(1):91–105 * decline in pediatric care by family physicians, 33(2):314–321 * virtual Parent Panel for pediatric research network, 33(5):665–674 * **China,** general practitioner job satisfaction, 33(3):456–459 * **Chondroitin,** glucosamine/chondroitin and mortality, 33(6):842–847 * **Chronic disease** * anti-hypertensive medication combinations, 33(1):143–146 * diagnosis and management of atopic dermatitis, 33(4):626–635 * heart disease in adult Down syndrome, 33(6):923–931 * intervention supports diabetes registry implementation, 33(5):728–735 * social and clinical complexity on diabetes control, 33(4):600–610 * sustainable preventive services in rural counties, 33(5):698–706 * systematic approach to opioid prescribing, 33(6):992–997 * treating fibromyalgia and physician burnout, 33(3):386–396 * **Chronic obstructive pulmonary disease (COPD)** * improving symptoms using team-based approach, 33(6):978–985 * inhaled corticosteroid treatment, 33(2):289–302 * **Chronic pain** * clinical decision support for opioid prescribing, 33(4):529–540 * management plans, changes to, 33(1):42–50 * opioid reduction protocol among rural patients, 33(4):502–511 * quality improvement toolkit to improve opioid prescribing, 33(1):17–26 * systematic approach to opioid prescribing, 33(6):992–997 * **Clinical decision-making** * changes to chronic pain management plans, 33(1):42–50 * mammography screening for average-risk women, 33(6):871–884 * patient education level and antidepressants, 33(1):80–90 * physicians’ response to quality-of-life goals, 33(1):71–79 * support for opioid prescribing, 33(4):529–540 * surveillance colonoscopies in older adults with prior adenomas, 33(5):796–798 * **Clinical decision rules,** machine learning approach to unhealthy drinking, 33(3):397–406 * **Clinical decision support systems,** for opioid prescribing, 33(4):529–540 * **Clinical medicine,** practical management of common skin injuries, 33(5):799–808 * **Clinical practice patterns,** project ECHO integrated within the ORPRN, 33(5):789–795 * **Cluster analysis,** treating fibromyalgia and physician burnout, 33(3):386–396 * **Cognitive dysfunction,** subjective vs. objective assessment, 33(3):417–425 * **Cohort studies** * glucosamine/chondroitin and mortality, 33(6):842–847 * health care satisfaction among opioid recipients, 33(1):34–41 * heart disease in adult Down syndrome, 33(6):923–931 * physician-pharmacist collaboration on diabetes outcomes, 33(5):745–753 * **Colonoscopy,** in older adults with prior adenomas, 33(5):796–798 * **Colorectal cancer** * screening, factors associated with, 33(5):779–784 * surveillance colonoscopies in older adults with prior adenomas, 33(5):796–798 * **Combined modality therapy,** office-based opioid treatment models, 33(4):512–521 * **Commentary** * The American Academy of Family Physician’s Approach to Developing and Supporting the Intrinsically Motivated Learner, 33(5):S21–S23 * The Built Environment for Professionalism, 33(5):S57–S61 * The Changing Face of Primary Care Research and Practice-Based Research Networks (PBRNs) in Light of the COVID-19 Pandemic, 33(5):645–649 * The Clinic is The Curriculum: Can Attention to the Clinical Learning Environment Enhance Improvement in Health Care Delivery and Outcomes?, 33(5):S46–S49 * Complexities in Integrating Social Risk Assessment into Health Care Delivery, 33(2):179–181 * Connecting Purpose and Performance: Rethinking the Purpose of Maintenance of Certification, 33(5):S15–S20 * The Dilution of Family Medicine: Waning Numbers of Family Physicians Providing Pediatric Care, 33(6):828–829 * Do Patients Want Help Addressing Social Risks?, 33(2):170–175 * Family Medicine and the “New” Opioid Epidemic, 33(1):1–3 * The Gender Penalty: Reasons for Differences in Reported Weekly Work Hours Among Male and Female Family Physicians, 33(5):650–652 * Helping Family Physicians Keep Up to Date: A Next Step in the Pursuit of Mastery, 33(5):S24–S27 * Medical Professionalism Is Like Pornography: You Know it When You See it, 33(5):S62–S64 * Positive Professionalism, 33(5):S65–S68 * Primary Care Teams: Past, Present and Future, 33(4):495–498 * Quality Improvement Teams: Moving from the Passionate Few to the Mandated Many, 33(5):S42–S45 * The Role of Certifying Boards in Improving Health: The Example of the American Board of Pediatrics, 33(5):S36–S41 * Trained and Ready, but Not Serving?—Family Physicians’ Role in Reproductive Health Care, 33(2):182–185 * When and How Do We Need Permission to Help Patients Address Social Risk?, 33(2):176–178 * Why Are Early Career Family Physicians Driving Increases in Buprenorphine Prescribing?, 33(1):4–6 * Women’s Work: Why Are Women Physicians More Burned Out?, 33(3):351–354 * **Communication** * breast cancer screening and shared decision making, 33(3):473–480 * educating patients on unnecessary antibiotics, 33(6):969–977 * patient interest in after-hours telemedicine, 33(5):765–773 * patient-provider teach-back communication with diabetic outcomes, 33(6):903–912 * physicians’ response to quality-of-life goals, 33(1):71–79 * **Communication disorders,** behavioral health problems and, 33(6):932–941 * **Community-based participatory research,** project ECHO integrated within the ORPRN, 33(5):789–795 * **Community health centers** * PBRN roadmap for evaluating COVID-19, 33(5):774–778 * social and clinical complexity on diabetes control, 33(4):600–610 * **Community health services,** project ECHO integrated within the ORPRN, 33(5):789–795 * **Community hospitals,** volunteers, 33(3):481–483 * **Comorbidity** * anti-hypertensive medication combinations, 33(1):143–146 * social and clinical complexity on diabetes control, 33(4):600–610 * widespread pain in adults with low back pain, 33(4):541–549 * **Comparative effectiveness research,** adapting diabetes shared medical appointments, 33(5):716–727 * **Compassion fatigue,** poem about asylum-seeker's torture, 33(5):815–815 * **Continuing medical education** * continuing board certification, 33(5):S10–S14 * helping family physicians keep up to date, 33(5):S24–S27 * intrinsically motivated learners, 33(5):S21–S23 * marketing messages in, on binge-eating disorder, 33(2):240–251 * project ECHO integrated within the ORPRN, 33(5):789–795 * **Continuity of patient care** * patient retention in opioid medication-assisted treatment, 33(6):848–857 * primary care and a population health improvement strategy, 33(3):468–472 * **Contraception** * physicians providing women’s health care services, 33(2):186–188 * role of family physicians in reproductive health care, 33(2):182–185 * **Contracts** * built environment for professionalism, 33(5):S57–S61 * medicine’s social contract, 33(5):S50–S56 * **Coronary artery disease,** anti-hypertensive medication combinations, 33(1):143–146 * **Coronavirus** * impact on primary care research and PBRNs, 33(5):645–649 * PBRN roadmap for evaluating, 33(5):774–778 * rebuilding after, planning systems of care, 33(3):485–488 * **Correspondence** * abnormally low hemoglobin A1c as harbinger of hemoglobinopathy, 33(2):342 * addressing needs of transgender patients: the role of family physicians, 33(5):818 * cervical spondylotic myelopathy: a guide to diagnosis and management, 33(6):1032 * does prescription opioid misuse affect the level of health care satisfaction endorsed by patients on opioid therapy?, 33(3):484 * identifying problematic substance use in a national sample of adolescents using frequency questions, 33(1):152 * marketing messages in CME modules on binge-eating disorder, 33(5):816–818 * new allopathic medical schools train fewer family physicians than older ones, 33(1):154–155 * primary care practices’ implementation of patient-team partnership: findings from EvidenceNOW Southwest, 33(2):342–343 * a successful walk-in psychiatric model for integrated care, 33(1):153–154 * sugar-sweetened beverage intake in a rural family medicine clinic, 33(1):152–153 * that clock is really big, 33(1):154 * three simple rules in pectoral muscle’s trigger point treatment, which may be a cause of chest pain, 33(6):1031 * **Cost-benefit analysis,** patient interest in after-hours telemedicine, 33(5):765–773 * **Cost savings,** physician-pharmacist collaboration on diabetes outcomes, 33(5):745–753 * **Counseling** * genetic, BRCA-related cancer, 33(6):885–893 * gestational diabetes risk and prenatal weight gain, 33(2):189–197 * **COVID-19** * impact on primary care research and PBRNs, 33(5):645–649 * PBRN roadmap for evaluating, 33(5):774–778 * rebuilding after, planning systems of care, 33(3):485–488 * **Creatinine,** anti-HMGCR myopathy from statins, 33(5):785–788 * **Cross-over studies,** opioid reduction protocol among rural patients, 33(4):502–511 * **Cross-sectional studies** * depression, rurality, and diabetes control, 33(6):913–922 * mammography screening for average-risk women, 33(6):871–884 * opioid use and driving among older adults, 33(4):521–528 * request denial and subsequent patient satisfaction, 33(1)51–58 * stimulant use by young adults for ADHD, 33(1):59–70 * treating fibromyalgia and physician burnout, 33(3):386–396 * usual source of care and longer telomere length, 33(6):832–841 * **Cultural competency,** addressing needs of transgender patients, 33(2):314–321 * **Curriculum,** clinical learning environment and health care delivery, 33(5):S46–S49 * **Data accuracy,** quality improvement teams, 33(5):S42–S45 * **Data analysis,** thyroid hormone use in the United States, 1997–2016, 33(2):284–288 * **Decision making** * breast cancer screening and, 33(3):473–480 * changes to chronic pain management plans, 33(1):42–50 * factors associated with colorectal cancer screening, 33(5):779–784 * initiative to reduce avoidable hospital admissions, 33(6):1011–1015 * mammography screening for average-risk women, 33(6):871–884 * PBRN roadmap for evaluating COVID-19, 33(5):774–778 * surveillance colonoscopies in older adults with prior adenomas, 33(5):796–798 * **Decision support techniques,** designing a prediabetes shared decision aid, 33(2):262–270 * **Decision trees,** machine learning approach to unhealthy drinking, 33(3):397–406 * **Delivery of health care** * built environment for professionalism, 33(5):S57–S61 * medicine’s social contract, 33(5):S50–S56 * PBRN roadmap for evaluating COVID-19, 33(5):774–778 * primary care and a population health improvement strategy, 33(3):468–472 * social risk assessment * integrating into health care delivery, 33(2):179–181 * patient desire for assistance, 33(2):170–175 * permission to help patients, 33(2):176–178 * workforce support of large-scale practice improvement, 33(2):230–239 * **Dementia,** subjective vs. objective assessment of cognitive functioning, 33(3):417–425 * **Demography,** patient education level and antidepressants, 33(1):80–90 * **Depersonalization** * general practitioner job satisfaction in China, 33(3):456–459 * treating fibromyalgia and physician burnout, 33(3):386–396 * **Depression** * patient education level and antidepressants, 33(1):80–90 * and rurality, association with glycemic control in diabetes, 33(6):913–922 * **Dermatology,** diagnosis and management of atopic dermatitis, 33(4):626–635 * **Dermoscopy,** in the primary care setting, 33(6):1022–1024 * **Diabetes mellitus** * adapting diabetes shared medical appointments, 33(5):716–727 * control, association of depression and rurality with, 33(6):913–922 * control measures, impact of social and clinical complexity on, 33(4):600–610 * designing a prediabetes shared decision aid, 33(2):262–270 * outcomes, physician-pharmacist collaboration on, 33(5):745–753. * patient-provider teach-back communication with diabetic outcomes, 33(6):903–912 * and periodontal disease, patients’ understanding of, 33(6):1004–1010 * **Diagnostic errors,** misdiagnosis of diverticulitis after IBS diagnosis, 33(4):549–560 * **Direct-to-consumer advertising,** prescription drug advertising and patient-provider interactions, 33(2):279–283 * **Disclosure,** perpetration of intimate partner violence, 33(5):809–814 * **Disease management** * anti-hypertensive medication combinations, 33(1):143–146 * opportunities to partner with patients living with diabetes, 33(2):211–219 * project ECHO integrated within the ORPRN, 33(5):789–795 * **Distance education,** project ECHO integrated within the ORPRN, 33(5):789–795 * **Diverticulitis,** misdiagnosis of, after IBS diagnosis, 33(4):549–560 * **Domestic violence,** perpetration of intimate partner violence, 33(5):809–814 * **Down syndrome,** heart disease in adults with, 33(6):923–931 * **Drug legislation,** managing patient requests for marijuana, 33(1):147–151 * **Drug overdose,** quality improvement toolkit to improve opioid prescribing, 33(1):17–26 * **Duration of therapy,** patient retention in opioid medication-assisted treatment, 33(6):848–857 * **Early detection of cancer** * BRCA-related cancer genetic counseling, 33(6):885–893 * breast cancer screening and shared decision making, 33(3):473–480 * factors associated with colorectal cancer screening, 33(5):779–784 * mammography screening for average-risk women, 33(6):871–884 * surveillance colonoscopies in older adults with prior adenomas, 33(5):796–798 * **Eczema,** diagnosis and management of atopic dermatitis, 33(4):626–635 * **Editorial,** Increasing Article Visibility: *JABFM* and Author Responsibilities and Possibilities, 33(2):168–169 * **Editorial Office News and Notes** * Dr. Victoria Neale Retires as Deputy Editor of JABFM, 33(5):643–644 * JABFM Welcomes a New Deputy Editor, 33(6):827 * The Most Frequently Read Articles of 2019, 33(4):491–494 * Peer Reviewers for the Journal of the American Board of Family Medicine in 2019, 33(2):164–167 * Welcome New Associate Editor for Reflections in Family Medicine, 33(3):350 * **Editors’ Notes** * Many Family Medicine Successful Interventions and Clinical Reviews for Common Illnesses, 33(2):161–163 * Medications, Medicating, and Medicated— When, Where, and How—Opioids and Others, 33(4):489–490 * Must-Read Family Medicine Research-Glucosamine/Chondroitin Supplements and Mortality, Telomere Length and the Doctor-Patient Relationship, Reducing Opioid Use, and More, 33(6):823–826 * Practical Family Medicine: After-Hours Video Telehealth, Office Procedures, Polyp Follow-up in Older Patients, Terminology for Domestic Violence Intervention, 33(5):641–642 * Well-Being, New Technologies, and Clinical Evidence for Family Physicians, 33(3):347–349 * **Efficiency,** team configurations and burnout, 33(3):368–377 * **Electronic health records** * asthma care in a multi-state network of low-income children, 33(5):707–715 * barriers to patient portal access and use, 33(6):953–968 * clinical care and nonindicated vitamin D testing, 33(4):569–579 * clinical decision support for opioid prescribing, 33(4):529–540 * eliminating barriers to improve quality of care, 33(2):220–229 * ethical questions raised by, 33(1): 106–117 * integrating data to assess patient risks, 33(3):463–467 * intervention supports diabetes registry implementation, 33(5):728–735 * practices reporting clinical quality measures, 33(4):620–625 * prognostic indices for advance care planning, 33(2):322–338 * proposed opioid tapering tool, 33(6):1020–1021 * reminder and hepatitis C screening, 33(6):1016–1019 * social and clinical complexity on diabetes control, 33(4):600–610 * sustainable preventive services in rural counties, 33(5):698–706 * **Electronic mail,** modifying provider vitamin D screening behavior, 33(2):252–261 * **Emergency departments,** co-management for sickle cell disease, 33(1):91–105 * **Emergency medicine,** practical management of common skin injuries, 33(5):799–808 * **Empathy,** hospital volunteers, 33(3):481–483 * **Eosinophils,** inhaled corticosteroid treatment in COPD, 33(2):289–302 * **Ethics** * impact of the EHR, 33(1): 106–117 * managing patient requests for marijuana, 33(1):147–151 * **Ethnic groups** * insurance, health care, and discrimination, 33(4):580–591 * successful follow-up of participants in a clinical trial, 33(3):431–439 * **Evidence-based medicine** * adapting diabetes shared medical appointments, 33(5):716–727 * current indications for tonsillectomy and adenoidectomy, 33(6):1025–1030 * PBRN roadmap for evaluating COVID-19, 33(5):774–778 * practical management of common skin injuries, 33(5):799–808 * risk-reduction tools and an opioid-prescribing protocol, 33(1):27–33 * uptake of changes to clinical preventive guidelines, 33(2):271–278 * **Evidence-based practice** * PBRN roadmap for evaluating COVID-19, 33(5):774–778 * workforce support of large-scale practice improvement, 33(2):230–239 * **Faculty** * clinical learning environment and health care delivery, 33(5):S46–S49 * peer review of abstracts submitted to academic meetings, 33(6):986–991 * **Family medicine** * celebrating 50 years of continuing transformation, 33(5):S69–S74 * changes in ACGME standards for, 33(6):1033–1036 * evolution of board certification, 33:(5)S1–S9 * helping family physicians keep up to date, 33(5):S24–S27 * initiative to reduce avoidable hospital admissions, 33(6):1011–1015 * OUD education and waiver provision during residency, 33(6):998–1003 * peer review of abstracts submitted to academic meetings, 33(6):986–991 * project ECHO integrated within the ORPRN, 33(5):789–795 * reflections *  hospital volunteers, 33(3):481–483 *  poem, 33(5):815 *  unexpected retirement, 33(2):339–341 * residency training, family medicine, 33(4):636–640 * systematic approach to opioid prescribing, 33(6):992–997 * **Family Medicine Certification Longitudinal Assessment (FMCLA),** after one year, 33(2):344–346 * **Family physicians** * buprenorphine prescribing by, 33(1):118–123 * burnout, and treating fibromyalgia, 33(3):386–396 * decline in pediatric care by, 33(2):314–321 * dermoscopy in the primary care setting, 33(6):1022–1024 * early-career, and prescribing buprenorphine, 33(1):7–8 * financial cost of medical assistant turnover, 33(3):426–430 * gender and work hours among, 33(5):653–654 * gender differences in addressing burnout, 33(3):446–451 * help in keeping up to date, 33(5):S24–S27 * identifying remedial predictors of burnout, 33(3):357–368 * intrinsically motivated learners, 33(5):S21–S23 * mammography screening for average-risk women, 33(6):871–884 * number caring for children, 33(6):830–831 * obesity intervention trial, participation of rural clinicians, 33(5):736–744 * opportunities to partner with patients living with diabetes, 33(2):211–219 * patient “catastrophizing” and expectations of opioid prescriptions, 33(6):858–870 * patient retention in opioid medication-assisted treatment, 33(6):848–857 * perpetration of intimate partner violence, 33(5):809–814 * physicians providing women’s health care services, 33(2):186–188 * role in addressing needs of transgender patients, 33(2):314–321 * role in reproductive health care, 33(2):182–185 * stimulant use by young adults for ADHD, 33(1):59–70 * team-based care, changes over time, 33(4):499–501 * team configurations, efficiency, and burnout, 33(3):368–377 * unexpected career retirement, 33(2):339–341 * **Fee-for-service plans** * financial model for opioid use disorder, 33(1):124–128 * high volume portal usage impacts resources, 33(3):452–456 * **Fibromyalgia,** treating, physician burnout and, 33(3):386–396 * **Financial models,** for opioid use disorder, 33(1):124–128 * **Focus groups** * Medicare Access and CHIP Reauthorization Act, 33(6):942–952 * patient safety in primary care, 33(5):754–764 * **Follow-up care,** social service touchpoints for diabetes screening, 33(4):616–619 * **Follow-up studies,** combating burnout in US Army health care, 33(3):440–445 * **Formative feedback,** rethinking the purpose of MOC, 33(5):S15–S20 * **Gait,** cervical spondylotic myelopathy, 33(2):303–313 * **Gender identity,** addressing needs of transgender patients, 33(2):314–321 * **General practitioners,** job satisfaction in China, 33(3):456–459 * **Genetic counseling,** BRCA-related cancer, 33(6):885–893 * **Genetic predisposition,** to BRCA-related cancers, 33(6):885–893 * **Georgia,** opportunities to partner with patients living with diabetes, 33(2):211–219 * **Geriatrics,** prescribing inappropriate medications for elderly patients, 33(4):561–568 * **Gestational diabetes** * risk and prenatal weight gain counseling, 33(2):189–197 * social service touchpoints for diabetes screening, 33(4):616–619 * **Gestational weight gain,** gestational diabetes risk and, 33(2):189–197 * **Global Initiative for Chronic Obstructive Lung Disease (GOLD),** inhaled corticosteroid treatment, 33(2):289–302 * **Glucosamine/chondroitin,** and mortality, 33(6):842–847 * **Glycated hemoglobin A,** diabetes control * association of depression and rurality with, 33(6):913–922 * impact of social and clinical complexity on, 33(4):600–610 * **Glycosylated hemoglobin,** physician-pharmacist collaboration on diabetes outcomes, 33(5):745–753 * **Goals,** clinical learning environment and health care delivery, 33(5):S46–S49 * **Guideline adherence** * anti-hypertensive medication combinations, 33(1):143–146 * intervention supports diabetes registry implementation, 33(5):728–735 * **Health behavior** * opportunities to partner with patients living with diabetes, 33(2):211–219 * patients’ understanding of diabetes and periodontal disease, 33(6):1004–1010 * **Health care disparities** * asthma care in a multi-state network of low-income children, 33(5):707–715 * social service touchpoints for diabetes screening, 33(4):616–619 * **Health equity,** social risk assessment * integrating into health care delivery, 33(2):179–181 * patient desire for assistance, 33(2):170–175 * permission to help patients with, 33(2):176–178 * **Health expenditures** * patient-provider teach-back communication with diabetic outcomes, 33(6):903–912 * thyroid hormone use in the United States, 1997–2016, 33(2):284–288 * **Health information exchange** * ethical questions raised by the EHR, 33(1): 106–117 * sustainable preventive services in rural counties, 33(5):698–706 * **Health insurance,** health care and discrimination, 33(4):580–591 * **Health literacy** * BRCA-related cancer genetic counseling, 33(6):885–893 * patient-provider teach-back communication with diabetic outcomes, 33(6):903–912 * **Health metrics,** practices reporting clinical quality measures, 33(4):620–625 * **Health personnel** * addressing needs of transgender patients, 33(2):314–321 * financial cost of medical assistant turnover, 33(3):426–430 * identifying remedial predictors of burnout, 33(3):357–368 * indicators of workplace burnout, 33(3):378–385 * patients’ understanding of diabetes and periodontal disease, 33(6):1004–1010 * prescription drug advertising and patient-provider interactions, 33(2):279–283 * strategies to overcome psychological insulin resistance, 33(2):198–210 * **Health policy** * medicine’s social contract, 33(5):S50–S56 * modifying provider vitamin D screening behavior, 33(2):252–261 * team-based care, changes over time, 33(4):499–501 * **Health promotion,** educating patients on unnecessary antibiotics, 33(6):969–977 * **Health services accessibility** * eliminating barriers to improve quality of care, 33(2):220–229 * gender and work hours among family physicians, 33(5):653–654 * OUD education and waiver provision during residency, 33(6):998–1003 * physicians providing women’s health care services, 33(2):186–188 * role of family physicians in reproductive health care, 33(2):182–185 * **Health services research** * thyroid hormone use in the United States, 1997–2016, 33(2):284–288 * virtual Parent Panel for pediatric research network, 33(5):665–674 * **Health status,** health care satisfaction among opioid recipients, 33(1):34–41 * **Health surveys,** health care satisfaction among opioid recipients, 33(1):34–41 * **Healthy aging,** usual source of care and longer telomere length, 33(6):832–841 * **Heart disease,** in adult Down syndrome, 33(6):923–931 * **Hematology,** co-management for sickle cell disease, 33(1):91–105 * **Hepatitis C** * EHR reminder and hepatitis C screening, 33(6):1016–1019 * screening interventions, models for, 33(3):407–416 * **Hispanic Americans,** asthma care in a multi-state network of low-income children, 33(5):707–715 * **Historically controlled study,** gestational diabetes risk and prenatal weight gain counseling, 33(2):189–197 * **HIV infections,** addressing needs of transgender patients, 33(2):314–321 * **HMG-CoA reductase inhibitors,** anti-HMGCR myopathy from statins, 33(5):785–788 * **Hobbies,** gender differences in addressing burnout, 33(3):446–451 * **Holistic health,** combating burnout in US Army health care, 33(3):440–445 * **Hospital emergency service,** initiative to reduce avoidable hospital admissions, 33(6):1011–1015 * **Hospitalization** * co-management for sickle cell disease, 33(1):91–105 * initiative to reduce avoidable hospital admissions, 33(6):1011–1015 * patient-provider teach-back communication with diabetic outcomes, 33(6):903–912 * **House calls,** eliminating barriers to improve quality of care, 33(2):220–229 * **Humanities,** poem about asylum-seeker’s torture, 33(5):815–815 * **Hydroxyurea,** co-management for sickle cell disease, 33(1):91–105 * **Hyperglycemia,** association of depression and rurality with glycemic control, 33(6):913–922 * **Hyperlipidemias** * among breast cancer survivors, 33(6):894–902 * anti-HMGCR myopathy from statins, 33(5):785–788 * **Hypertension** * anti-hypertensive medication combinations, 33(1):143–146 * gestational diabetes risk and prenatal weight gain counseling, 33(2):189–197 * **Hypertrophy,** current indications for tonsillectomy and adenoidectomy, 33(6):1025–1030 * **Hypothyroidism,** thyroid hormone use in the United States, 1997–2016, 33(2):284–288 * **Illinois,** gender differences in addressing burnout, 33(3):446–451 * **Implementation science** * adapting diabetes shared medical appointments, 33(5):716–727 * PBRN roadmap for evaluating COVID-19, 33(5):774–778 * uptake of changes to clinical preventive guidelines, 33(2):271–278 * **Incidence** * breast cancer screening and shared decision making, 33(3):473–480 * misdiagnosis of diverticulitis after IBS diagnosis, 33(4):549–560 * **Independent living,** prognostic indices for advance care planning, 33(2):322–338 * **Information dissemination,** PBRN roadmap for evaluating COVID-19, 33(5):774–778 * **Information technology** * barriers to patient portal access and use, 33(6):953–968 * clinical decision support for opioid prescribing, 33(4):529–540 * **Inhaled corticosteroids,** treatment in COPD, 33(2):289–302 * **Inpatients,** hospital volunteers, 33(3):481–483 * **Insulin resistance,** psychological, strategies to overcome, 33(2):198–210 * **Insurance coverage,** insurance, health care, and discrimination, 33(4):580–591 * **Interdisciplinary research,** Medicare Access and CHIP Reauthorization Act, 33(6):942–952 * **Internal medicine,** prescribing inappropriate medications for elderly patients, 33(4):561–568 * **Internship and residency,** patient retention in opioid medication-assisted treatment, 33(6):848–857 * **Interrupted time series analysis,** modifying provider vitamin D screening behavior, 33(2):252–261 * **Intimate partner violence,** perpetration of, 33(5):809–814 * **Irritable bowel syndrome (IBS),** diagnosis, misdiagnosis of diverticulitis after, 33(4):549–560 * **Job satisfaction** * combating burnout in US Army health care, 33(3):440–445 * general practitioner, in China, 33(3):456–459 * identifying remedial predictors of burnout, 33(3):357–368 * indicators of workplace burnout, 33(3):378–385 * ***Journal of the American Board of Family Medicine (JABFM)*** * author responsibilities and possibilities, 33(2):168–169 * most frequently read articles of 2019, 33(4):491–494 * new deputy editor, 33(6):827 * peer reviewers for, 33(2):164–167 * retirement of deputy editor, 33(5):643–644 * **Lacerations,** practical management of common skin injuries, 33(5):799–808 * **Leadership,** quality improvement toolkit to improve opioid prescribing, 33(1):17–26 * **Learning** * clinical learning environment and health care delivery, 33(5):S46–S49 * intrinsically motivated learners, 33(5):S21–S23 * **Leukocytes,** usual source of care and longer telomere length, 33(6):832–841 * **Licensure** * medical professionalism, 33(5):S62–S64 * positive professionalism, 33(5):S65–S68 * **Life expectancy,** surveillance colonoscopies in older adults with prior adenomas, 33(5):796–798 * **Lifestyle,** opportunities to partner with patients living with diabetes, 33(2):211–219 * **Limited English proficiency,** barriers to patient portal access and use, 33(6):953–968 * **Linear models** * educating patients on unnecessary antibiotics, 33(6):969–977 * usual source of care and longer telomere length, 33(6):832–841 * **Lipid management,** in breast cancer survivors, 33(6):894–902 * **Lisdexamfetamine,** marketing messages in continuing medical education on binge-eating disorder, 33(2):240–251 * **Logistic models** * barriers to patient portal access and use, 33(6):953–968 * behavioral health problems and communication disabilities, 33(6):932–941 * buprenorphine prescribing by family physicians, 33(1):118–123 * depression, rurality, and diabetes control, 33(6):913–922 * gestational diabetes risk and prenatal weight gain counseling, 33(2):189–197 * HPV vaccination among adult males, 33(4):592–599 * insurance, health care, and discrimination, 33(4):580–591 * machine learning approach to unhealthy drinking, 33(3):397–406 * patient “catastrophizing” and expectations of opioid prescriptions, 33(6):858–870 * social and clinical complexity on diabetes control, 33(4):600–610 * treating fibromyalgia and physician burnout, 33(3):386–396 * **Longitudinal studies,** patient-provider teach-back communication with diabetic outcomes, 33(6):903–912 * **Low back pain** * opioid prescriptions for new low back pain, 33(1):138–142 * widespread pain in adults with, 33(4):541–549 * **Low value care,** clinical care and nonindicated vitamin D testing, 33(4):569–579 * **Lupus,** reflections in family medicine, 33(2):339–341 * **Machine learning,** approach to unhealthy drinking, 33(3):397–406 * **Mammography,** breast cancer screening * for average-risk women, 33(6):871–884 * and shared decision making, 33(3):473–480 * **Managed care programs,** physician-pharmacist collaboration on diabetes outcomes, 33(5):745–753 * **Marijuana use,** managing patient requests, 33(1):147–151 * **Maryland** * educating patients on unnecessary antibiotics, 33(6):969–977 * identifying remedial predictors of burnout, 33(3):357–368 * surveillance colonoscopies in older adults with prior adenomas, 33(5):796–798 * **Mass screening,** surveillance colonoscopies in older adults with prior adenomas, 33(5):796–798 * **Medicaid** * co-management for sickle cell disease, 33(1):91–105 * eliminating barriers to improve quality of care, 33(2):220–229 * financial model for opioid use disorder, 33(1):124–128 * insurance, health care, and discrimination, 33(4):580–591 * **Medical education** * clinical learning environment and health care delivery, 33(5):S46–S49 * medicine’s social contract, 33(5):S50–S56 * positive professionalism, 33(5):S65–S68 * **Medical errors,** continuing board certification, 33(5):S10–S14 * **Medical ethics** * built environment for professionalism, 33(5):S57–S61 * ethical questions raised by the EHR, 33(1): 106–117 * managing patient requests for marijuana, 33(1):147–151 * poem about asylum-seeker’s torture, 33(5):815–815 * **Medical informatics** * barriers to patient portal access and use, 33(6):953–968 * ethical questions raised by the EHR, 33(1): 106–117 * **Medical marijuana,** managing patient requests for, 33(1):147–151 * **Medical staff privileges,** positive professionalism, 33(5):S65–S68 * **Medical students** * clinical learning environment and health care delivery, 33(5):S46–S49 * hospital volunteers, 33(3):481–483 * **Medically underserved areas** * physicians providing women’s health care services, 33(2):186–188 * role of family physicians in reproductive health care, 33(2):182–185 * **Medicare** * patients, buprenorphine prescribers for, 33(1):9–16 * Medicare Access and CHIP Reauthorization Act, 33(6):942–952 * prescribing inappropriate medications for elderly patients, 33(4):561–568 * **Memory,** subjective vs. objective assessment of cognitive functioning, 33(3):417–425 * **Men’s health,** HPV vaccination, 33(4):592–599 * **Mental health** * adapting diabetes shared medical appointments, 33(5):716–727 * addressing needs of transgender patients, 33(2):314–321 * behavioral health problems and communication disabilities, 33(6):932–941 * patient education level and antidepressants, 33(1):80–90 * poem about asylum-seeker’s torture, 33(5):815–815 * **Mental health services,** buprenorphine prescribing by family physicians, 33(1):118–123 * **Mental status and dementia tests,** subjective vs. objective assessment, 33(3):417–425 * **Mentors,** intervention supports diabetes registry implementation: from ACORN, 33(5):728–735 * **Mexico,** unexpected career retirement, 33(2):339–341 * **Military medicine** * anti-HMGCR myopathy from statins, 33(5):785–788 * combating burnout in US Army health care, 33(3):440–445 * **Military personnel,** combating burnout in US Army health care, 33(3):440–445 * **Minnesota,** depression, rurality, and diabetes control, 33(6):913–922 * **Minority groups,** successful follow-up of participants in a clinical trial, 33(3):431–439 * **Minority health,** co-management for sickle cell disease, 33(1):91–105 * **Motivation** * adapting diabetes shared medical appointments, 33(5):716–727 * intrinsically motivated learners, 33(5):S21–S23 * obesity intervention trial, participation of rural clinicians, 33(5):736–744 * **Multivariate analysis** * behavioral health problems and communication disabilities, 33(6):932–941 * prescribing inappropriate medications for elderly patients, 33(4):561–568 * **Muscle weakness,** anti-HMGCR myopathy from statins, 33(5):785–788 * **Muscular diseases,** anti-HMGCR myopathy from statins, 33(5):785–788 * **Myopathy,** anti-HMGCR, from statins, 33(5):785–788 * **Myositis,** anti-HMGCR myopathy from statins, 33(5):785–788 * **Naltrexone,** office-based opioid treatment models, 33(4):512–521 * **Narcotic antagonists,** office-based opioid treatment models, 33(4):512–521 * **Native Americans,** reflections in family medicine, 33(2):339–341 * **Neural networks (computer),** machine learning approach to unhealthy drinking, 33(3):397–406 * **Nevada,** opportunities to partner with patients living with diabetes, 33(2):211–219 * **North Carolina** * co-management for sickle cell disease, 33(1):91–105 * eliminating barriers to improve quality of care, 33(2):220–229 * **Nutrition surveys** * glucosamine/chondroitin and mortality, 33(6):842–847 * machine learning approach to unhealthy drinking, 33(3):397–406 * usual source of care and longer telomere length, 33(6):832–841 * **Obesity** * among breast cancer survivors, 33(6):894–902 * intervention trial, participation of rural clinicians, 33(5):736–744 * opportunities to partner with patients living with diabetes, 33(2):211–219 * **Observer variation,** peer review of abstracts submitted to academic meetings, 33(6):986–991 * **Obstetrics,** gestational diabetes risk and prenatal weight gain counseling, 33(2):189–197 * **Obstructive sleep apnea,** current indications for tonsillectomy and adenoidectomy, 33(6):1025–1030 * **Occupational stress,** general practitioner job satisfaction in China, 33(3):456–459 * **Oklahoma,** sustainable preventive services in rural counties, 33(5):698–706 * **Opiate substitution treatment,** office-based opioid treatment models, 33(4):512–521 * **Opioid epidemic,** opioid reduction protocol among rural patients, 33(4):502–511 * **Opioid-related disorders** * buprenorphine prescribers for Medicare patients, 33(1):9–16 * buprenorphine prescribing by family physicians, 33(1):118–123 * clinical decision support for opioid prescribing, 33(4):529–540 * early-career physicians and prescribing buprenorphine, 33(1):7–8 * financial model for opioid use disorder, 33(1):124–128 * office-based opioid treatment models, 33(4):512–521 * opioid reduction protocol among rural patients, 33(4):502–511 * opioid use and driving among older adults, 33(4):521–528 * OUD education and waiver provision during residency, 33(6):998–1003 * patient “catastrophizing” and expectations of opioid prescriptions, 33(6):858–870 * patient retention in opioid medication-assisted treatment, 33(6):848–857 * quality improvement toolkit to improve opioid prescribing, 33(1):17–26 * systematic approach to opioid prescribing, 33(6):992–997 * treating opioid use disorder in family medicine, 33(4):611–615 * **Opioids** * changes to chronic pain management plans, 33(1):42–50 * financial model for opioid use disorder, 33(1):124–128 * opioid reduction protocol among rural patients, 33(4):502–511 * opioid use and driving among older adults, 33(4):521–528 * patient retention in opioid medication-assisted treatment, 33(6):848–857 * prescribing *  buprenorphine, by family physicians, 33(1):118–123 *  buprenorphine, early-career physicians and, 33(1):7–8 *  buprenorphine, for Medicare patients, 33(1):9–16 *  protocol, risk-reduction tools and, 33(1):27–33 *  quality improvement toolkit to improve, 33(1):17–26 *  systematic approach to, 33(6):992–997 * prescriptions *  expectations of, patient “catastrophizing” and, 33(6):858–870 *  for new low back pain, 33(1):138–142 *  recipients of, health care satisfaction among, 33(1):34–41 * proposed tapering tool, 33(6):1020–1021 * **Oral hygiene,** patients’ understanding of diabetes and periodontal disease, 33(6):1004–1010 * **Oregon,** project ECHO integrated within the ORPRN, 33(5):789–795 * **Organizational innovation** * combating burnout in US Army health care, 33(3):440–445 * intervention supports diabetes registry implementation: from ACORN, 33(5):728–735 * PBRN roadmap for evaluating COVID-19, 33(5):774–778 * quality improvement toolkit to improve opioid prescribing, 33(1):17–26 * **Osteoarthritis,** glucosamine/chondroitin and mortality, 33(6):842–847 * **Otolaryngology,** current indications for tonsillectomy and adenoidectomy, 33(6):1025–1030 * **Outcome measures,** quality improvement toolkit to improve opioid prescribing, 33(1):17–26 * **Outcomes assessment** * anti-hypertensive medication combinations, 33(1):143–146 * behavioral health problems and communication disabilities, 33(6):932–941 * clinical decision support for opioid prescribing, 33(4):529–540 * opioid reduction protocol among rural patients, 33(4):502–511 * patient-provider teach-back communication with diabetic outcomes, 33(6):903–912 * **Outpatients** * BRCA-related cancer genetic counseling, 33(6):885–893 * health care satisfaction among opioid recipients, 33(1):34–41 * misdiagnosis of diverticulitis after IBS diagnosis, 33(4):549–560 * opioid prescriptions for new low back pain, 33(1):138–142 * patient “catastrophizing” and expectations of opioid prescriptions, 33(6):858–870 * request denial and subsequent patient satisfaction, 33(1)51–58 * **Overuse,** clinical care and nonindicated vitamin D testing, 33(4):569–579 * **Ownership,** Medicare Access and CHIP Reauthorization Act, 33(6):942–952 * **Pain** * health care satisfaction among opioid recipients, 33(1):34–41 * opioid use and driving among older adults, 33(4):521–528 * risk-reduction tools and an opioid-prescribing protocol, 33(1):27–33 * widespread, in adults with low back pain, 33(4):541–549 * **Pain management** * patient “catastrophizing” and expectations of opioid prescriptions, 33(6):858–870 * plans, changes to, 33(1):42–50 * proposed opioid tapering tool, 33(6):1020–1021 * treating fibromyalgia and physician burnout, 33(3):386–396 * **Pandemics,** PBRN roadmap for evaluating COVID-19, 33(5):774–778 * **Papillomavirus infections,** HPV vaccination among adult males, 33(4):592–599 * **Parents,** virtual Parent Panel for pediatric research network, 33(5):665–674 * **Patient care** * gender and work hours among family physicians, 33(5):653–654 * integrating data to assess patient risks, 33(3):463–467 * prescription drug advertising and patient-provider interactions, 33(2):279–283 * social and clinical complexity on diabetes control, 33(4):600–610 * **Patient care team** * adapting diabetes shared medical appointments, 33(5):716–727 * changes over time, 33(4):499–501 * combating burnout in US Army health care, 33(3):440–445 * social risk assessment *  integrating into health care delivery, 33(2):179–181 *  patient desire for assistance, 33(2):170–175 *  permission to help patients, 33(2):176–178 * team configurations, efficiency, and burnout, 33(3):368–377 * treating fibromyalgia and physician burnout, 33(3):386–396 * **Patient-centered care** * combating burnout in US Army health care, 33(3):440–445 * high volume portal usage impacts resources, 33(3):452–456 * patient-provider teach-back communication with diabetic outcomes, 33(6):903–912 * patient safety in primary care, 33(5):754–764 * physicians’ response to quality-of-life goals, 33(1):71–79 * proposed opioid tapering tool, 33(6):1020–1021 * strategies to overcome psychological insulin resistance, 33(2):198–210 * treating opioid use disorder in family medicine, 33(4):611–615 * **Patient discharge,** initiative to reduce avoidable hospital admissions, 33(6):1011–1015 * **Patient health questionnaire,** risk-reduction tools and an opioid-prescribing protocol, 33(1):27–33 * **Patient navigation,** patients’ understanding of diabetes and periodontal disease, 33(6):1004–1010 * **Patient participation** * patient education level and antidepressants, 33(1):80–90 * physicians’ response to quality-of-life goals, 33(1):71–79 * practice transformation support and cardiovascular care, 33(5):675–686 * **Patient portals** * barriers to access and use, 33(6):953–968 * high volume portal usage impacts resources, 33(3):452–456 * physician factors and inbox message volume, 33(3):460–462 * **Patient preference** * educating patients on unnecessary antibiotics, 33(6):969–977 * patient education level and antidepressants, 33(1):80–90 * social risk assessment *  integrating into health care delivery, 33(2):179–181 *  patient desire for assistance, 33(2):170–175 *  permission to help patients, 33(2):176–178 * **Patient readmission,** eliminating barriers to improve quality of care, 33(2):220–229 * **Patient safety** * clinical learning environment and health care delivery, 33(5):S46–S49 * in primary care, 33(5):754–764 * stimulant use by young adults for ADHD, 33(1):59–70 * systematic approach to opioid prescribing, 33(6):992–997 * **Patient satisfaction** * after request denial, 33(1)51–58 * with health care, among opioid recipients, 33(1):34–41 * **Pay for performance** * measuring and improving quality in the US, 33(5):S28–S35 * Medicare Access and CHIP Reauthorization Act, 33(6):942–952 * **Pediatricians,** decline in pediatric care by family physicians, 33(2):314–321 * **Pediatrics,** role of certifying boards in improving health, 33(5):S36–S41 * **Peer review,** of abstracts submitted to academic meetings, 33(6):986–991 * **Periodontal disease,** diabetes and, patients’ understanding of, 33(6):1004–1010 * **Personal health records,** barriers to patient portal access and use, 33(6):953–968 * **Personal satisfaction** * request denial and subsequent patient satisfaction, 33(1)51–58 * unexpected career retirement, 33(2):339–341 * **Personnel selection,** financial cost of medical assistant turnover, 33(3):426–430 * **Personnel turnover** * financial cost of medical assistant turnover, 33(3):426–430 * indicators of workplace burnout, 33(3):378–385 * practice facilitation barriers in quality improvement, 33(5):655–664 * **Pharmacists,** physician-pharmacist collaboration on diabetes outcomes, 33(5):745–753 * **Physician-patient relations** * ethical questions raised by the EHR, 33(1): 106–117 * factors associated with colorectal cancer screening, 33(5):779–784 * request denial and subsequent patient satisfaction, 33(1)51–58 * **Physicians** * continuing board certification, 33(5):S10–S14 * evolution of board certification, 33:(5)S1–S9 * indicators of workplace burnout, 33(3):378–385 * physician-pharmacist collaboration on diabetes outcomes, 33(5):745–753 * positive professionalism, 33(5):S65–S68 * quality improvement teams, 33(5):S42–S45 * response to quality-of-life goals, 33(1):71–79 * **Physicians’ practice patterns** * opioid prescriptions for new low back pain, 33(1):138–142 * opioid reduction protocol among rural patients, 33(4):502–511 * patient “catastrophizing” and expectations of opioid prescriptions, 33(6):858–870 * **Pilot studies,** proposed opioid tapering tool, 33(6):1020–1021 * **Population health** * integrating data to assess patient risks, 33(3):463–467 * modifying provider vitamin D screening behavior, 33(2):252–261 * primary care and a population health improvement strategy, 33(3):468–472 * social risk assessment * integrating into health care delivery, 33(2):179–181 * patient desire for assistance, 33(2):170–175 * permission to help patients, 33(2):176–178 * **Potentially inappropriate medications,** prescribing, for elderly patients, 33(4):561–568 * **Poverty,** asthma care in a multi-state network of low-income children, 33(5):707–715 * **Practice-based research** * adapting diabetes shared medical appointments, 33(5):716–727 * asthma care in a multi-state network of low-income children, 33(5):707–715 * factors associated with colorectal cancer screening, 33(5):779–784 * intervention supports diabetes registry implementation: from ACORN, 33(5):728–735 * obesity intervention trial, participation of rural clinicians, 33(5):736–744 * patient safety in primary care, 33(5):754–764 * PBRN roadmap for evaluating COVID-19, 33(5):774–778 * physician-pharmacist collaboration on diabetes outcomes, 33(5):745–753 * practice facilitation barriers in quality improvement, 33(5):655–664 * practice transformation support and cardiovascular care, 33(5):675–686 * project ECHO integrated within the ORPRN, 33(5):789–795 * sustainable preventive services in rural counties, 33(5):698–706 * virtual Parent Panel for pediatric research network, 33(5):665–674 * **Practice-based research networks (PBRNs),** impact of COVID-19, 33(5):645–649 * **Practice facilitation,** practice facilitation barriers in quality improvement, 33(5):655–664 * **Prediabetes** * designing a prediabetes shared decision aid, 33(2):262–270 * opportunities to partner with patients living with diabetes, 33(2):211–219 * **Prediabetic state,** social service touchpoints for diabetes screening, 33(4):616–619 * **Pregnancy,** social service touchpoints for diabetes screening, 33(4):616–619 * **Pregnancy complications,** gestational diabetes risk and prenatal weight gain counseling, 33(2):189–197 * **Prescription drug monitoring programs,** clinical decision support for opioid prescribing, 33(4):529–540 * **Prescription drugs,** advertising, patient-provider interactions and, 33(2):279–283 * **Prescriptions** * early-career physicians and prescribing buprenorphine, 33(1):7–8 * health care satisfaction among opioid recipients, 33(1):34–41 * opioid prescriptions for new low back pain, 33(1):138–142 * risk-reduction tools and an opioid-prescribing protocol, 33(1):27–33 * **Prevalence** * cardiovascular disease in breast cancer survivors, 33(6):894–902 * heart disease in adult Down syndrome, 33(6):923–931 * identifying remedial predictors of burnout, 33(3):357–368 * widespread pain in adults with low back pain, 33(4):541–549 * **Preventive health services** * EHR reminder and hepatitis C screening, 33(6):1016–1019 * heart disease in adult Down syndrome, 33(6):923–931 * sustainable, in rural counties, 33(5):698–706 * workforce support of large-scale practice improvement, 33(2):230–239 * **Preventive medicine,** uptake of changes to clinical preventive guidelines, 33(2):271–278 * **Primary care physicians** * dermoscopy in the primary care setting, 33(6):1022–1024 * ethical questions raised by the EHR, 33(1): 106–117 * opioid prescriptions for new low back pain, 33(1):138–142 * prescribing inappropriate medications for elderly patients, 33(4):561–568 * request denial and subsequent patient satisfaction, 33(1)51–58 * **Primary health care** * adapting diabetes shared medical appointments, 33(5):716–727 * barriers to patient portal access and use, 33(6):953–968 * breast cancer screening and shared decision making, 33(3):473–480 * built environment for professionalism, 33(5):S57–S61 * buprenorphine prescribing, 33(1):118–123 * changes to chronic pain management plans, 33(1):42–50 * clinical care and nonindicated vitamin D testing, 33(4):569–579 * co-management for sickle cell disease, 33(1):91–105 * decline in pediatric care by family physicians, 33(2):314–321 * dermoscopy in the primary care setting, 33(6):1022–1024 * designing a prediabetes shared decision aid, 33(2):262–270 * diagnosis and management of atopic dermatitis, 33(4):626–635 * educating patients on unnecessary antibiotics, 33(6):969–977 * eliminating barriers to improve quality of care, 33(2):220–229 * factors associated with colorectal cancer screening, 33(5):779–784 * financial cost of medical assistant turnover, 33(3):426–430 * identifying remedial predictors of burnout, 33(3):357–368 * improving COPD symptoms using team-based approach, 33(6):978–985 * indicators of workplace burnout, 33(3):378–385 * intervention supports diabetes registry implementation: from ACORN, 33(5):728–735 * mammography screening for average-risk women, 33(6):871–884 * Medicare Access and CHIP Reauthorization Act, 33(6):942–952 * misdiagnosis of diverticulitis after IBS diagnosis, 33(4):549–560 * modifying provider vitamin D screening behavior, 33(2):252–261 * obesity intervention trial, participation of rural clinicians, 33(5):736–744 * office-based opioid treatment models, 33(4):512–521 * opioid prescriptions for new low back pain, 33(1):138–142 * patient education level and antidepressants, 33(1):80–90 * patient interest in after-hours telemedicine, 33(5):765–773 * patient-provider teach-back communication with diabetic outcomes, 33(6):903–912 * patient retention in opioid medication-assisted treatment, 33(6):848–857 * patient safety in, 33(5):754–764 * PBRN roadmap for evaluating COVID-19, 33(5):774–778 * peer review of abstracts submitted to academic meetings, 33(6):986–991 * perpetration of intimate partner violence, 33(5):809–814 * physician factors and inbox message volume, 33(3):460–462 * physician-pharmacist collaboration on diabetes outcomes, 33(5):745–753 * physicians providing women’s health care services, 33(2):186–188 * population health improvement strategy, 33(3):468–472 * practical management of common skin injuries, 33(5):799–808 * practice transformation support and cardiovascular care, 33(5):675–686 * practices reporting clinical quality measures, 33(4):620–625 * prescribing inappropriate medications for elderly patients, 33(4):561–568 * prognostic indices for advance care planning, 33(2):322–338 * project ECHO integrated within the ORPRN, 33(5):789–795 * proposed opioid tapering tool, 33(6):1020–1021 * quality improvement, barriers in, 33(5):655–664 * quality improvement toolkit to improve opioid prescribing, 33(1):17–26 * risk-reduction tools and an opioid-prescribing protocol, 33(1):27–33 * role of family physicians in reproductive health care, 33(2):182–185 * social and clinical complexity on diabetes control, 33(4):600–610 * subjective vs. objective assessment of cognitive functioning, 33(3):417–425 * surveillance colonoscopies in older adults with prior adenomas, 33(5):796–798 * sustainable preventive services in rural counties, 33(5):698–706 * systematic approach to opioid prescribing, 33(6):992–997 * team-based care, changes over time, 33(4):499–501 * treating fibromyalgia and physician burnout, 33(3):386–396 * treating opioid use disorder in family medicine, 33(4):611–615 * usual source of care and longer telomere length, 33(6):832–841 * workforce support of large-scale practice improvement, 33(2):230–239 * **Process measures,** quality improvement toolkit to improve opioid prescribing, 33(1):17–26 * **Professional autonomy,** continuing board certification, 33(5):S10–S14 * **Professional burnout** * combating burnout in US Army health care, 33(3):440–445 * gender differences in addressing, 33(3):446–451 * identifying remedial predictors of, 33(3):357–368 * indicators of workplace burnout, 33(3):378–385 * team configurations, efficiency, and burnout, 33(3):368–377 * treating fibromyalgia and, 33(3):386–396 * **Professionalism** * approach to monitoring and enhancing, 33(5):S62–S64 * built environment for, 33(5):S57–S61 * evaluation of, 33(5):S65–S68 * evolution of board certification, 33:(5)S1–S9 * medicine’s social contract, 33(5):S50–S56 * **Prognosis,** indices for advance care planning, 33(2):322–338 * **Proportional hazards models** * glucosamine/chondroitin and mortality, 33(6):842–847 * patient retention in opioid medication-assisted treatment, 33(6):848–857 * **Psychological distress,** behavioral health problems and communication disabilities, 33(6):932–941 * **Psychotherapy,** office-based opioid treatment models, 33(4):512–521 * **PTSD,** poem about asylum-seeker’s torture, 33(5):815–815 * **Public health** * buprenorphine prescribers for Medicare patients, 33(1):9–16 * educating patients on unnecessary antibiotics, 33(6):969–977 * general practitioner job satisfaction in China, 33(3):456–459 * sustainable preventive services in rural counties, 33(5):698–706 * **Public health surveillance,** integrating data to assess patient risks, 33(3):463–467 * **Qualitative research** * changes to chronic pain management plans, 33(1):42–50 * ethical questions raised by the EHR, 33(1): 106–117 * obesity intervention trial, participation of rural clinicians, 33(5):736–744 * office-based opioid treatment models, 33(4):512–521 * opportunities to partner with patients living with diabetes, 33(2):211–219 * patient safety in primary care, 33(5):754–764 * surveillance colonoscopies in older adults with prior adenomas, 33(5):796–798 * uptake of changes to clinical preventive guidelines, 33(2):271–278 * workforce support of large-scale practice improvement, 33(2):230–239 * **Quality improvement** * clinical care and nonindicated vitamin D testing, 33(4):569–579 * eliminating barriers to, 33(2):220–229 * evolution of board certification, 33:(5)S1–S9 * improving COPD symptoms using team-based approach, 33(6):978–985 * initiative to reduce avoidable hospital admissions, 33(6):1011–1015 * measuring, 33(5):S28–S35 * Medicare Access and CHIP Reauthorization Act, 33(6):942–952 * positive professionalism, 33(5):S65–S68 * practice facilitation barriers in, 33(5):655–664 * practice transformation support and cardiovascular care, 33(5):675–686 * practices reporting clinical quality measures, 33(4):620–625 * project ECHO integrated within the ORPRN, 33(5):789–795 * teams, 33(5):S42–S45 * toolkit to improve opioid prescribing, 33(1):17–26 * workforce support of, 33(2):230–239 * **Quality of health care** * clinical learning environment and health care delivery, 33(5):S46–S49 * ethical questions raised by the EHR, 33(1): 106–117 * measuring and improving quality in the US, 33(5):S28–S35 * opioid prescriptions for new low back pain, 33(1):138–142 * role of certifying boards in improving health, 33(5):S36–S41 * **Quality of life** * diagnosis and management of atopic dermatitis, 33(4):626–635 * goals, physicians’ response to, 33(1):71–79 * marketing messages in continuing medical education on binge-eating disorder, 33(2):240–251 * stimulant use by young adults for ADHD, 33(1):59–70 * widespread pain in adults with low back pain, 33(4):541–549 * **Racism,** insurance, health care, and discrimination, 33(4):580–591 * **Rare diseases,** anti-HMGCR myopathy from statins, 33(5):785–788 * **Reductase,** anti-HMGCR myopathy from statins, 33(5):785–788 * **Referral and consultation** * patient safety in primary care, 33(5):754–764 * perpetration of intimate partner violence, 33(5):809–814 * **Refugees,** poem about asylum-seeker’s torture, 33(5):815–815 * **Registries** * integrating data to assess patient risks, 33(3):463–467 * intervention supports diabetes registry implementation: from ACORN, 33(5):728–735 * quality improvement toolkit to improve opioid prescribing, 33(1):17–26 * sustainable preventive services in rural counties, 33(5):698–706 * widespread pain in adults with low back pain, 33(4):541–549 * **Regression analysis** * general practitioner job satisfaction in China, 33(3):456–459 * models for hepatitis C screening interventions, 33(3):407–416 * physician factors and inbox message volume, 33(3):460–462 * practice facilitation barriers in quality improvement, 33(5):655–664 * request denial and subsequent patient satisfaction, 33(1)51–58 * **Reproductive health** * physicians providing women’s health care services, 33(2):186–188 * role of family physicians, 33(2):182–185 * **Residency** * early-career physicians and prescribing buprenorphine, 33(1):7–8 * OUD education and waiver provision during residency, 33(6):998–1003 * patient retention in opioid medication-assisted treatment, 33(6):848–857 * physicians providing women’s health care services, 33(2):186–188 * requirements, impact of ACGME’s June 2019 changes in, 33(6):1033–1036 * risk-reduction tools and an opioid-prescribing protocol, 33(1):27–33 * role of family physicians in reproductive health care, 33(2):182–185 * training, family medicine, future of, 33(4):636–640 * **Retirement** * gender and work hours among family physicians, 33(5):653–654 * unexpected career retirement, 33(2):339–341 * **Retrospective studies** * behavioral health problems and communication disabilities, 33(6):932–941 * cardiovascular screening and lipid management in breast cancer survivors, 33(6):894–902 * financial cost of medical assistant turnover, 33(3):426–430 * financial model for opioid use disorder, 33(1):124–128 * heart disease in adult Down syndrome, 33(6):923–931 * improving COPD symptoms using team-based approach, 33(6):978–985 * misdiagnosis of diverticulitis after IBS diagnosis, 33(4):549–560 * patient-provider teach-back communication with diabetic outcomes, 33(6):903–912 * patient retention in opioid medication-assisted treatment, 33(6):848–857 * physician-pharmacist collaboration on diabetes outcomes, 33(5):745–753 * prescribing inappropriate medications for elderly patients, 33(4):561–568 * successful follow-up of participants in a clinical trial, 33(3):431–439 * **Risk assessment** * breast cancer screening and shared decision making, 33(3):473–480 * integrating data to assess patient risks, 33(3):463–467 * opioid use and driving among older adults, 33(4):521–528 * quality improvement toolkit to improve opioid prescribing, 33(1):17–26 * surveillance colonoscopies in older adults with prior adenomas, 33(5):796–798 * **Risk factors** * cardiovascular disease among breast cancer survivors, 33(6):894–902 * depression, rurality, and diabetes control, 33(6):913–922 * models for hepatitis C screening interventions, 33(3):407–416 * practice transformation support and cardiovascular care, 33(5):675–686 * social and clinical complexity on diabetes control, 33(4):600–610 * social risk assessment * integrating into health care delivery, 33(2):179–181 * patient desire for assistance, 33(2):170–175 * permission to help patients, 33(2):176–178 * social service touchpoints for diabetes screening, 33(4):616–619 * **Risk-reduction tools,** and an opioid-prescribing protocol, 33(1):27–33 * **Risk taking,** HPV vaccination among adult males, 33(4):592–599 * **Rural health** * buprenorphine prescribing by family physicians, 33(1):118–123 * and depression, association with glycemic control, 33(6):913–922 * obesity intervention trial, participation of rural clinicians, 33(5):736–744 * opioid reduction protocol, 33(4):502–511 * sustainable preventive services, 33(5):698–706 * **Screening** * cardiovascular, in breast cancer survivors, 33(6):894–902 * for colorectal cancer, factors associated with, 33(5):779–784 * hepatitis C * EHR reminder and, 33(6):1016–1019 * models for screening interventions, 33(3):407–416 * social service touchpoints for diabetes screening, 33(4):616–619 * **Self care,** combating burnout in US Army health care, 33(3):440–445 * **Self-management** * opportunities to partner with patients living with diabetes, 33(2):211–219 * patients’ understanding of diabetes and periodontal disease, 33(6):1004–1010 * **Self report,** request denial and subsequent patient satisfaction, 33(1)51–58 * **Sexual and gender minorities,** addressing needs of transgender patients, 33(2):314–321 * **Sexual health** * physicians providing women’s health care services, 33(2):186–188 * role of family physicians in reproductive health care, 33(2):182–185 * **Shared decision making** * breast cancer screening and, 33(3):473–480 * initiative to reduce avoidable hospital admissions, 33(6):1011–1015 * **Shared medical appointments,** diabetes, 33(5):716–727 * **Sickle-cell anemia,** co-management for, 33(1):91–105 * **Skin cancer,** dermoscopy in the primary care setting, 33(6):1022–1024 * **Skin diseases,** atopic dermatitis, diagnosis and management, 33(4):626–635 * **Smokers,** improving COPD symptoms using team-based approach, 33(6):978–985 * **Social determinants of health** * integrating data to assess patient risks, 33(3):463–467 * models for hepatitis C screening interventions, 33(3):407–416 * primary care and a population health improvement strategy, 33(3):468–472 * social and clinical complexity on diabetes control, 33(4):600–610 * social risk assessment * integrating into health care delivery, 33(2):179–181 * patient desire for assistance, 33(2):170–175 * permission to help patients, 33(2):176–178 * **Social justice** * medicine’s social contract, 33(5):S50–S56 * poem about asylum-seeker’s torture, 33(5):815–815 * **Social responsibility,** continuing board certification, 33(5):S10–S14 * **Social support,** opportunities to partner with patients living with diabetes, 33(2):211–219 * **Social work** * social risk assessment * integrating into health care delivery, 33(2):179–181 * patient desire for assistance, 33(2):170–175 * permission to help patients, 33(2):176–178 * social service touchpoints for diabetes screening, 33(4):616–619 * **Socioeconomic status,** physician factors and inbox message volume, 33(3):460–462 * **Software,** proposed opioid tapering tool, 33(6):1020–1021 * **Special communications** * A Change Management Case Study for Safe Opioid Prescribing and Opioid Use Disorder Treatment, 33(1):129–137 * How We Talk About “Perpetration of Intimate Partner Violence” Matters, 33(5):809–814 * Integrating Community and Clinical Data to Assess Patient Risks with A Population Health Assessment Engine (PHATE), 33(3):463–467 * Primary Care Is an Essential Ingredient to a Successful Population Health Improvement Strategy, 33(3):468–472 * **Specialization,** continuing board certification, 33(5):S10–S14 * **Specialty boards** * celebrating 50 years of continuing transformation, 33(5):S69–S74 * helping family physicians keep up to date, 33(5):S24–S27 * positive professionalism, 33(5):S65–S68 * **Speech,** behavioral health problems and communication disabilities, 33(6):932–941 * **Spinal cord diseases,** cervical spondylotic myelopathy, 33(2):303–313 * **Spondylosis,** cervical spondylotic myelopathy, 33(2):303–313 * **Spouse abuse,** 33(5):809–814 * **Stakeholder participation** * adapting diabetes shared medical appointments, 33(5):716–727 * virtual Parent Panel for pediatric research network, 33(5):665–674 * **Statins** * anti-HMGCR myopathy from, 33(5):785–788 * lipid management in breast cancer survivors, 33(6):894–902 * **Streptococcal infections,** current indications for tonsillectomy and adenoidectomy, 33(6):1025–1030 * **Substance-related disorders** * addressing needs of transgender patients, 33(2):314–321 * behavioral health problems and communication disabilities, 33(6):932–941 * **Support vector machine,** machine learning approach to unhealthy drinking, 33(3):397–406 * **Surveys and questionnaires** * adapting diabetes shared medical appointments, 33(5):716–727 * anti-hypertensive medication combinations, 33(1):143–146 * barriers to patient portal access and use, 33(6):953–968 * behavioral health problems and communication disabilities, 33(6):932–941 * combating burnout in US Army health care, 33(3):440–445 * dermoscopy in the primary care setting, 33(6):1022–1024 * designing a prediabetes shared decision aid, 33(2):262–270 * educating patients on unnecessary antibiotics, 33(6):969–977 * eliminating barriers to improve quality of care, 33(2):220–229 * factors associated with colorectal cancer screening, 33(5):779–784 * gender and work hours among family physicians, 33(5):653–654 * gender differences in addressing burnout, 33(3):446–451 * general practitioner job satisfaction in China, 33(3):456–459 * health care satisfaction among opioid recipients, 33(1):34–41 * identifying remedial predictors of burnout, 33(3):357–368 * indicators of workplace burnout, 33(3):378–385 * insurance, health care, and discrimination, 33(4):580–591 * nutrition surveys *  glucosamine/chondroitin and mortality, 33(6):842–847 *  machine learning approach to unhealthy drinking, 33(3):397–406 *  usual source of care and longer telomere length, 33(6):832–841 * opioid use and driving among older adults, 33(4):521–528 * OUD education and waiver provision during residency, 33(6):998–1003 * patient “catastrophizing” and expectations of opioid prescriptions, 33(6):858–870 * patient education level and antidepressants, 33(1):80–90 * patient interest in after-hours telemedicine, 33(5):765–773 * patient-provider teach-back communication with diabetic outcomes, 33(6):903–912 * patients’ understanding of diabetes and periodontal disease, 33(6):1004–1010 * physicians’ response to quality-of-life goals, 33(1):71–79 * practice transformation support and cardiovascular care, 33(5):675–686 * practices reporting clinical quality measures, 33(4):620–625 * prescription drug advertising and patient-provider interactions, 33(2):279–283 * quality improvement toolkit to improve opioid prescribing, 33(1):17–26 * stimulant use by young adults for ADHD, 33(1):59–70 * strategies to overcome psychological insulin resistance, 33(2):198–210 * subjective vs. objective assessment of cognitive functioning, 33(3):417–425 * team-based care, changes over time, 33(4):499–501 * team configurations, efficiency, and burnout, 33(3):368–377 * virtual Parent Panel for pediatric research network, 33(5):665–674 * **Survivorship,** cardiovascular disease among breast cancer survivors, 33(6):894–902 * **Telemedicine** * after-hours, patient interest in, 33(5):765–773 * barriers to patient portal access and use, 33(6):953–968 * project ECHO integrated within the ORPRN, 33(5):789–795 * **Telomere length,** longer, and usual source of care, 33(6):832–841 * **Tertiary care centers,** ethical questions raised by the EHR, 33(1): 106–117 * **Thiazides,** anti-hypertensive medication combinations, 33(1):143–146 * **Thyroid hormones,** use in the United States, 1997–2016, 33(2):284–288 * **Time series algorithms,** practice facilitation barriers in quality improvement, 33(5):655–664 * **Tonsillectomy,** current indications for, 33(6):1025–1030 * **Torture,** asylum-seeker’s, poem about, 33(5):815–815 * **Training support,** helping family physicians keep up to date, 33(5):S24–S27 * **Tramadol,** risk-reduction tools and an opioid-prescribing protocol, 33(1):27–33 * **Translational medical research,** clinical decision support for opioid prescribing, 33(4):529–540 * **Treatment outcome,** treating opioid use disorder in family medicine, 33(4):611–615 * **Trensgender persons,** addressing needs of, 33(2):314–321 * **Type 2 diabetes** * intervention supports diabetes registry implementation: from ACORN, 33(5):728–735 * opportunities to partner with patients living with, 33(2):211–219 * social service touchpoints for diabetes screening, 33(4):616–619 * strategies to overcome psychological insulin resistance, 33(2):198–210 * **Uncertainty,** clinical care and nonindicated vitamin D testing, 33(4):569–579 * **United States** * strategies to overcome psychological insulin resistance, 33(2):198–210 * thyroid hormone use, 1997–2016, 33(2):284–288 * **United States Indian Health Service,** unexpected career retirement, 33(2):339–341 * **Universities,** stimulant use by young adults for ADHD, 33(1):59–70 * **Urology,** medical professionalism, 33(5):S62–S64 * **Value-based purchasing,** measuring and improving quality in the US, 33(5):S28–S35 * **Variance analysis,** patient education level and antidepressants, 33(1):80–90 * **Veterans health,** anti-HMGCR myopathy from statins, 33(5):785–788 * **Video recording,** physicians’ response to quality-of-life goals, 33(1):71–79 * **Violence,** addressing needs of transgender patients, 33(2):314–321 * **Virginia** * indicators of workplace burnout, 33(3):378–385 * intervention supports diabetes registry implementation: from ACORN, 33(5):728–735 * Medicare Access and CHIP Reauthorization Act, 33(6):942–952 * office-based opioid treatment models, 33(4):512–521 * **Vitamin D** * provider screening behavior, modifying, 33(2):252–261 * testing, nonindicated, clinical care and, 33(4):569–579 * **Volunteers,** hospital, 33(3):481–483 * **Vulnerable populations** * BRCA-related cancer genetic counseling, 33(6):885–893 * co-management for sickle cell disease, 33(1):91–105 * factors associated with colorectal cancer screening, 33(5):779–784 * **Weight loss** * marketing messages in continuing medical education on binge-eating disorder, 33(2):240–251 * obesity intervention trial, participation of rural clinicians, 33(5):736–744 * **West Virginia,** improving COPD symptoms using team-based approach, 33(6):978–985 * **Women physicians** * gender and work hours among family physicians, 33(5):653–654 * gender differences in addressing burnout, 33(3):446–451 * **Women’s health** * BRCA-related cancer genetic counseling, 33(6):885–893 * gestational diabetes risk and prenatal weight gain counseling, 33(2):189–197 * mammography screening for average-risk women, 33(6):871–884 * role of family physicians in reproductive health care, 33(2):182–185 * services provided by family physicians, 33(2):186–188 * social service touchpoints for diabetes screening, 33(4):616–619 * **Work engagement,** practice facilitation barriers in quality improvement, 33(5):655–664 * **Workflow,** quality improvement toolkit to improve opioid prescribing, 33(1):17–26 * **Workforce** * gender and work hours among family physicians, 33(5):653–654 * identifying remedial predictors of burnout, 33(3):357–368 * OUD education and waiver provision during residency, 33(6):998–1003 * physicians providing women’s health care services, 33(2):186–188 * practice facilitation barriers in quality improvement, 33(5):655–664 * role of family physicians in reproductive health care, 33(2):182–185 * **Workload** * physician factors and inbox message volume, 33(3):460–462 * treating fibromyalgia and physician burnout, 33(3):386–396 * **Workplace** * burnout, indicators of, 33(3):378–385 * combating burnout in US Army health care, 33(3):440–445 * **Young adults,** stimulant use by, for ADHD, 33(1):59–70